Compounded medications, including but not limited to Semaglutide, Tirzepatide, and peptide therapies, are not FDA-approved. These are distinct, customized preparations and are not “generic” versions of Ozempic®, Wegovy®, or Mounjaro®. The FDA does not review compounded drugs for safety, effectiveness, or quality.
These medications are prepared in FDA-registered 503B outsourcing facilities or state-licensed 503A pharmacies to meet the specific medical needs of an individual patient. Compounded medications and peptides have not been evaluated by the U.S. Food and Drug Administration (FDA) in the same manner as FDA-approved, commercially manufactured drugs.
All medical weight loss treatments and peptide therapies are prescription-only and require a comprehensive medical evaluation and consultation with a licensed healthcare provider to determine medical appropriateness. Results vary by individual, and no specific outcomes are guaranteed.
Miami Bariatric and Plastic Surgery MD is a medical clinic, not a pharmacy, and does not manufacture or dispense medications directly. Medications are prescribed when clinically appropriate and fulfilled by licensed third-party pharmacies.
Telehealth services are provided only to patients physically located in the state of Florida at the time of the medical encounter, in accordance with state and federal regulations.
For questions or to schedule a consultation, call (786) 294-6054.
If you experience a medical emergency, call 911 immediately.